Seaport Therapeutics, Inc. Common Stock (SPTX) — Defensive Interval Ratio

Latest as of December 2025: 4853 days

Seaport Therapeutics, Inc. Common Stock (SPTX) has a Defensive Interval Ratio of 4853 days as of December 2025. Defensive assets of $169.94 Million (cash $-, short-term investments $169.94 Million, receivables $-) cover 4853 days of daily cash needs of $35.02K/day. See SPTX total equity for net asset value and shareholders' equity analysis.

Defensive Interval Ratio

4853 days
Days of operational coverage

Defensive Assets

$169.94 Million
Cash + ST Investments + Receivables

Daily Cash Need

$35.02K
Current Liabilities ÷ 365

Current Liabilities

$12.78 Million
USD

Seaport Therapeutics, Inc. Common Stock Defensive Interval Ratio (2024–2025)

This chart shows how Seaport Therapeutics, Inc. Common Stock's Defensive Interval Ratio has evolved across 2 annual periods from 2024 to 2025. As of December 2025, the ratio stands at 4853 days, meaning defensive assets of $169.94 Million can fund 4853 days of operations without new revenue. Explore Seaport Therapeutics, Inc. Common Stock (SPTX) cash flow conversion to assess how effectively this company generates cash.

Annual Defensive Interval Ratio for Seaport Therapeutics, Inc. Common Stock (2024–2025)

The table below presents the year-by-year Defensive Interval Ratio for Seaport Therapeutics, Inc. Common Stock from 2024 to 2025, covering 2 annual filings. Each row shows defensive assets, daily cash need, the DIR in days, and the change in days compared to the prior year. For live market cap and the full company financial profile, see Seaport Therapeutics, Inc. Common Stock market cap and net worth.

Year DIR (days) Defensive Assets (USD) Daily Cash Need Cash ST Investments Change (days)
2025 4853 days $169.94 Million $35.02K/day $- $169.94 Million ▲ +4853 days
2024 0 days $0.00 $30.55K/day $- $0.00
DIR = (Cash + Short-term Investments + Net Receivables) / (Daily Cash Expenses)